Gili Kenet

Research interests

Publications

• Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial

  The Lancet Haematology · 2023 · https://doi.org/10.1016/s2352-3026(23)00037-6

• Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A

  New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2211075

• Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

  The Lancet Haematology · 2019 · https://doi.org/10.1016/s2352-3026(19)30219-4

• Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A

  Blood · 2019 · https://doi.org/10.1182/blood.2019000658

• Factor VIII Products and Inhibitor Development in Severe Hemophilia A

  New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1208024

• Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children

  Journal of Thrombosis and Haemostasis · 2011 · https://doi.org/10.1111/j.1538-7836.2011.04433.x

• Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors

  Haematologica · 2010 · https://doi.org/10.3324/haematol.2010.026989

• Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children

  Circulation · 2010 · https://doi.org/10.1161/circulationaha.109.913673

• Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma‐derived or recombinant factor VIII concentrates: a systematic review

  Journal of Thrombosis and Haemostasis · 2010 · https://doi.org/10.1111/j.1538-7836.2010.03823.x

• Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study

  Blood · 2010 · https://doi.org/10.1182/blood-2010-01-263012

• Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors

  Haemophilia · 2008 · https://doi.org/10.1111/j.1365-2516.2008.01829.x

• Impact of Inherited Thrombophilia on Venous Thromboembolism in Children

  Circulation · 2008 · https://doi.org/10.1161/circulationaha.108.789008

• Factor V Leiden and Antiphospholipid Antibodies in Either Mothers or Infants Increase the Risk for Perinatal Arterial Ischemic Stroke

  Stroke · 2008 · https://doi.org/10.1161/strokeaha.108.527283

• Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study

  The Lancet Neurology · 2007 · https://doi.org/10.1016/s1474-4422(07)70131-x

• Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors

  Thrombosis and Haemostasis · 2006 · https://doi.org/10.1160/th05-07-0510

• Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial.

  PubMed · 2006

• Promoter Polymorphisms in the Plasma Glutathione Peroxidase ( GPx-3 ) Gene

  Stroke · 2006 · https://doi.org/10.1161/01.str.0000252027.53766.2b

• Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors

  Journal of Thrombosis and Haemostasis · 2004 · https://doi.org/10.1111/j.1538-7836.2004.00759.x

• A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven®)

  Journal of Thrombosis and Haemostasis · 2003 · https://doi.org/10.1046/j.1538-7836.2003.00059.x

• Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma

  The Journal of Trauma: Injury, Infection, and Critical Care · 2001 · https://doi.org/10.1097/00005373-200109000-00002

• Factor V Leiden and Antiphospholipid Antibodies Are Significant Risk Factors for Ischemic Stroke in Children

  Stroke · 2000 · https://doi.org/10.1161/01.str.31.6.1283

• Treatment of traumatic bleeding with recombinant factor VIIa

  The Lancet · 1999 · https://doi.org/10.1016/s0140-6736(99)05155-7

Current projects

No projects listed.